| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $21.9M | +519.3% |
| SG&A Expense | $6.1M | -29.8% |
| Operating Income | -$28.0M | -128.7% |
| Pre-tax Income | -$34.0M | -175.6% |
| Income Tax | $221K | — |
| Net Income | -$34.3M | -177.4% |
| EPS (Basic) | -$7.13 | +43.1% |
| EPS (Diluted) | -$7.13 | +43.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.5M | -56.1% |
| Current Assets | $8.4M | -49.0% |
| Total Assets | $90.2M | -4.4% |
| Current Liabilities | $3.1M | -3.7% |
| Total Liabilities | $15.3M | -49.1% |
| Stockholders' Equity | $74.9M | +839.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.6M | -77.7% |
| Investing Cash Flow | $3.8M | +0.0% |
| Financing Cash Flow | $7.3M | -56.4% |